Literature DB >> 18987964

Impact of a comprehensive safety program on radiation exposure during catheter ablation of atrial fibrillation: a prospective study.

Dhanunjaya Lakkireddy1, George Nadzam, Atul Verma, Subramanya Prasad, Kay Ryschon, Luigi Di Biase, Mohammed Khan, David Burkhardt, Robert Schweikert, Andrea Natale.   

Abstract

BACKGROUND: Pulmonary vein antral isolation (PVAI) is an effective treatment for atrial fibrillation and involves prolonged procedure and fluoroscopy times. This study assesses the impact of a comprehensive radiation safety program on patient and operator radiation exposure during PVAI. METHODS AND
RESULTS: We evaluated a comprehensive radiation safety program including: (1) verbal reinforcement of previous fluoroscopy times (2) effective collimation (3) minimizing source-intensifier distance and (4) effective lead shield use. Exposure doses in 41 consecutive patients without (group-I, n = 21) and with (group-II, n = 20) the use of radiation safety program were assessed. PVAI was done using intracardiac echo (ICE) guided roving circular mapping catheter. A 3-dimensional mapping system was used in 27% cases for additional guidance. Operator and patient exposure was measured during the PVAI. The age, gender, body mass index and AF duration were similar in both of the groups. The total procedure (166 +/- 56 vs 178 +/- 38 min, p = 0.54) and fluoroscopy times (74 +/- 24 vs 70 +/- 20 min, p = 0.72) were comparable. Group-II had significantly lower dose area product (234 +/- 120 vs 548 +/- 363 Gy cm(2), p = 0.03) compared to group-I. The mean operator exposure was reduced by half and mean patient peak skin dose by three to ten times with comprehensive radiation safety program. None of the patients were noted to have radiation related skin injuries. Additional lifetime cancer risk was significantly lower in group-II patients (0.08 vs 0.2%, p < 0.001) than group-I.
CONCLUSIONS: Implementation of a comprehensive radiation safety program described above significantly decreases the radiation exposure to the patient as well as the operator.

Entities:  

Mesh:

Year:  2008        PMID: 18987964     DOI: 10.1007/s10840-008-9316-0

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  24 in total

Review 1.  Should atrial fibrillation ablation be considered first-line therapy for some patients? Why atrial fibrillation ablation should be considered first-line therapy for some patients.

Authors:  Atul Verma; Andrea Natale
Journal:  Circulation       Date:  2005-08-23       Impact factor: 29.690

2.  Accurate assessment of patient effective radiation dose and associated detriment risk from radiofrequency catheter ablation procedures.

Authors:  K Perisinakis; J Damilakis; N Theocharopoulos; E Manios; P Vardas; N Gourtsoyiannis
Journal:  Circulation       Date:  2001-07-03       Impact factor: 29.690

3.  [Catheter ablation of paroxysmal atrial fibrillation].

Authors:  F Sacher; P Jaïs; M Hocini; S Reuter; P Bordachar; S Garrigue; M Haïssaguerre; J Clémenty
Journal:  Arch Mal Coeur Vaiss       Date:  2004-10

4.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.

Authors:  Oussama M Wazni; Nassir F Marrouche; David O Martin; Atul Verma; Mandeep Bhargava; Walid Saliba; Dianna Bash; Robert Schweikert; Johannes Brachmann; Jens Gunther; Klaus Gutleben; Ennio Pisano; Dominico Potenza; Raffaele Fanelli; Antonio Raviele; Sakis Themistoclakis; Antonio Rossillo; Aldo Bonso; Andrea Natale
Journal:  JAMA       Date:  2005-06-01       Impact factor: 56.272

Review 5.  Fluoroscopy and the skin: implications for radiofrequency catheter ablation.

Authors:  G T Nahass
Journal:  Am J Cardiol       Date:  1995-07-15       Impact factor: 2.778

6.  Effective dose to personnel wearing protective aprons during fluoroscopy and interventional radiology.

Authors:  M Rosenstein; E W Webster
Journal:  Health Phys       Date:  1994-07       Impact factor: 1.316

7.  Radiation exposure during catheter ablation of atrial fibrillation.

Authors:  Lars Lickfett; Mahadevappa Mahesh; Chandra Vasamreddy; David Bradley; Vinod Jayam; Zayd Eldadah; Timm Dickfeld; Deborah Kearney; Darshan Dalal; Berndt Lüderitz; Ronald Berger; Hugh Calkins
Journal:  Circulation       Date:  2004-10-25       Impact factor: 29.690

8.  Patient and staff radiation dosimetry during cardiac electrophysiology studies and catheter ablation procedures: a comprehensive analysis.

Authors:  Efstathios P Efstathopoulos; Demosthenes G Katritsis; Sofia Kottou; Nectarios Kalivas; Efthalia Tzanalaridou; Eleftherios Giazitzoglou; Socrates Korovesis; Keith Faulkner
Journal:  Europace       Date:  2006-05-11       Impact factor: 5.214

9.  Acute radiation dermatitis following radiofrequency catheter ablation of atrioventricular nodal reentrant tachycardia.

Authors:  L S Rosenthal; T J Beck; J Williams; M Mahesh; M G Herman; J L Dinerman; H Calkins; J H Lawrence
Journal:  Pacing Clin Electrophysiol       Date:  1997-07       Impact factor: 1.976

Review 10.  [The place of ablation in the treatment of atrial fibrillation: where are we and where are we going?].

Authors:  P Jaïs; M Hocini; F Sacher; J Clémenty; M Haïssaguerre
Journal:  Arch Mal Coeur Vaiss       Date:  2004-11
View more
  9 in total

1.  Point-by-point pulmonary vein antrum isolation guided by intracardiac echocardiography and 3D mapping and duty-cycled multipolar AF ablation: effect of multipolar ablation on procedure duration and fluoroscopy time.

Authors:  Yaariv Khaykin; Lauren Zarnett; Daniel Friedlander; Zaev A Wulffhart; Bonnie Whaley; David Giewercer; Bernice Tsang; Atul Verma
Journal:  J Interv Card Electrophysiol       Date:  2012-03-11       Impact factor: 1.900

2.  Impact of nonfluoroscopic MediGuide™ tracking system on radiation exposure in radiofrequency ablation procedures (LESS-RADS registry)-an initial experience.

Authors:  Ajay Vallakati; Yeruva Madhu Reddy; Martin Emert; Pramod Janga; Moussa C Mansour; E Kevin Heist; Rhea Pimentel; Raghuveer Dendi; Donita Atkins; Sudharani Bommana; Srijoy Mahapatra; Michael Heard; Jeremy Ruskin; Loren Berenbom; Buddhadeb Dawn; Dhanunjaya Lakkireddy
Journal:  J Interv Card Electrophysiol       Date:  2013-09-12       Impact factor: 1.900

Review 3.  New X-ray imaging modalities and their integration with intravascular imaging and interventions.

Authors:  H Hetterich; T Redel; G Lauritsch; C Rohkohl; J Rieber
Journal:  Int J Cardiovasc Imaging       Date:  2009-11-08       Impact factor: 2.357

4.  CARTO-guided vs. NavX-guided pulmonary vein antrum isolation and pulmonary vein antrum isolation performed without 3-D mapping: effect of the 3-D mapping system on procedure duration and fluoroscopy time.

Authors:  Yaariv Khaykin; Richard Oosthuizen; Lauren Zarnett; Zaev A Wulffhart; Bonnie Whaley; Carol Hill; David Giewercer; Atul Verma
Journal:  J Interv Card Electrophysiol       Date:  2011-01-21       Impact factor: 1.900

5.  Atrial Flutter Ablation Using MediGuideTM Non-fluoroscopic Catheter Tracking System: A Novel Technology to Reduce Radiation Exposure.

Authors:  Anand Pillai; Madhu Reddy; Michael Heard; Ajay Vallakati; Loren Berenbom; Dhanunjaya Lakkireddy
Journal:  J Atr Fibrillation       Date:  2012-10-06

6.  Reduction of radiation exposure during ablation of atrial fibrillation.

Authors:  Ralph Schneider; Jörg Lauschke; Cindy Schneider; Tina Tischer; Aenne Glass; Dietmar Bänsch
Journal:  Herz       Date:  2015-05-20       Impact factor: 1.443

Review 7.  Catheter Ablation of Atrial Fibrillation Without Radiation Exposure Using A 3D Mapping System.

Authors:  Marco Scaglione; Elisa Ebrille; Francesca Di Clemente; Fiorenzo Gaita; Jason S Bradfield
Journal:  J Atr Fibrillation       Date:  2015-02-28

8.  Observations and Considerations on Patient X-ray Exposure in the Electrophysiology Lab.

Authors:  Xianxian Jiang; Lukas Rc Dekker
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11-29

9.  Extremely low-frame-rate digital fluoroscopy in catheter ablation of atrial fibrillation: A comparison of 2 versus 4 frame rate.

Authors:  Ji Hyun Lee; Jun Kim; Minsu Kim; Jongmin Hwang; You Mi Hwang; Joon-Won Kang; Gi-Byoung Nam; Kee-Joon Choi; You-Ho Kim
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.